The inhibitor of apoptosis proteins (IAPs) constitute a family of highly conserved apoptosis suppressor proteins that was originally identified in baculoviruses. Although IAP homologs have been recently identified and demonstrated to suppress apoptosis in mammalian cells, their expression and role during follicular development and atresia are unknown. The present study was conducted to address these questions. Using established in vivo models for the induction of follicular development and atresia in immature rats, it was possible to compare the immunolocalization of X-link inhibitor of apoptosis protein (Xiap) and human inhibitor of apoptosis protein-2 (Hiap-2), two members of the IAP family, at defined stages of follicular maturation and to relate the differences observed with those of follicular cell proliferation and apoptosis [as determined by proliferating cell nuclear antigen (PCNA) immunohistochemistry and in situ terminal deoxynucleotidyl transferase-mediated dUTP-biotin end labeling (TUNEL), respectively]. In addition, granulosa cell DNA and proteins were assessed for apoptotic fragmentation by 3Ј-end labeling/agarose gel electrophoresis (DNA ladder) and Hiap-2 and Xiap protein content by Western blot analysis, respectively. Hiap-2 and Xiap expression in both granulosa and theca cells increased with follicular maturation, reaching maximal levels at the antral stage of development. The immunoreactivity for PCNA, Xiap, and Hiap-2 decreased markedly in atretic (TUNEL-positive) follicles at the small to medium sized antral stage of development, suggesting follicular atresia may be associated with decreased granulosa cell IAP protein content and decreased proliferation. Atresia was also associated with a change in the intracellular distribution of IAPs in granulosa cells. Biochemical analysis of DNA fragmentation (DNA ladder) in granulosa cells from preantral and early antral follicles indicates extensive apoptosis that was associated with minimal IAP protein content. Gonadotropin treatment increased Hiap-2 and Xiap protein content and suppressed apoptosis in granulosa cells, resulting in the development of follicles to the antral and preovulatory stages. In addition, gonadotropin withdrawal induced apoptotic DNA fragmentation in granulosa cells in early antral and antral follicles, which is accompanied by a marked decrease in Hiap-2 and Xiap expression. These data suggest that IAPs may be involved in the suppression of granulosa cell apoptosis by gonadotropin in small to medium-sized antral follicles and play an important role in determining the fate of the cells, and thus also the eventual follicular destiny (atresia vs. ovulation). (Endocrinology 139: [1321][1322][1323][1324][1325][1326][1327][1328] 1998) 
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Inhibitor of apoptosis proteins (IAPs) is a novel family of intracellular proteins that suppress apoptosis induced by a variety of stimuli, including growth factor deprivation, menadione (a potent inducer of free radicals), and transient transfection of pro-interleukin-1␤ converting enzyme (9 -11) . IAPs were first identified in baculoviruses, where they function to keep the host cell alive, whereas the viruses replicate (12, 13) . Four IAPs have been identified in the mammal: neuronal apoptosis inhibitory protein (NAIP,14), X-link inhibitor of apoptosis protein (XIAP, 9; miha, 11; ilp, 10), human inhibitor of apoptosis protein-1 (HIAP-1, 9; cIAP-2, 15; mihc, 11) and human inhibitor of apoptosis protein-2 (HIAP-2, 9; cIAP-1, 15; mihb, 11). With the exception of NAIP, which only has the N-terminal repeats named baculovirus IAP repeats (BIRs), all other mammalian IAPs identified to date possessed both N-terminal BIRs and a C-terminal RING zing finger domain. Although these proteins have been detected in whole ovarian extracts (9) , their precise cellular localization and physiologic role in ovarian follicular development and atresia are unknown. Sufficient gonadotropin support is the most critical survival stimulus for preantral and antral follicles in the process of follicle selection and development (1, 4, 5, 16, 17) . We have previously established an in vivo model in which gonadotropin withdrawal by anti-eCG antibody administration rapidly induces apoptosis in small-to medium-size antral follicles, a critical stage of development when atresia is commonly observed (18) . This model has provided a valuable tool to examine possible signaling mechanisms and early events associated with the induction of rat granulosa cell apoptosis and follicular atresia. The objective of the present study was to establish the presence of IAPs in rat granulosa and theca cells and to study the role and regulation of IAP expression in follicular development and atresia, using established in vivo models of gonadotropin stimulation and withdrawal. We report the presence of Xiap and Hiap-2 in rat granulosa and theca cells, the expression of which appeared to be developmentally regulated. While the abundance of the IAPs in granulosa cells increased with follicular development to the antral stage, levels of these antiapoptotic proteins were markedly suppressed following the induction of follicular atresia.
Materials and Methods Materials
10% neutral buffered formalin, xylene, ethanol, paraffin, acetic acid, EDTA, and MgCl 2 were purchased from BDH (Toronto, Ontario, Canada). Ethidium bromide, diethylstilbestrol (DES), equine CG (eCG), human CG (hCG), agarose, Hoescht 33248, acridine orange, Tris, PBS, protease K, phenylmethylsulifonyl fluoride (PMSF), goat serum, and eCG were from Sigma Chemical Co. (St. Louis, MO). Klenow enzyme, ECL Western blotting detection kit, and [␣ 32 P]-ddATP (3000 Ci/mmol) were obtained from Amersham (Arlington Heights, IL). Medium M199 and normal rabbit serum were from Gibco-BRL (Burlington, Ontario, Canada). -probe blotting membrane, trans-blot supported nitrocellulose membrane, acrylamide (electrophoresis grade), N,NЈ-methylenebis-acrylamide, ammonium persulfate, tetramethylethylene diamine, DTT, glycine, SDS-PAGE prestained molecular weight standards (low range), and Bio-Rad protein assay kit were purchased from Bio-Rad Laboratories (Hercules, CA). X-ray films were from Eastman Kodak Company (Rochester, NY). Positively charged slides were from Fisher Scientific (Probe On Plus, Nepean, Ontario, Canada). The anti-eCG antibody was a gift from Dr. D. Johnson (University of Kansas, Kansas City, KS). The rabbit polyclonal anti-Xiap and Hiap-2 antibodies were prepared by immunization with human Xiap and Hiap-2 GST fusion protein (Korneluk, R. G., manuscript in preparation). The PCNA antibody was from Santa Cruz Biotechnology (Santa Cruz, CA).
Animal preparation
For the assessment of granulosa and theca cell apoptosis and IAP expression during follicular maturation, different stages of follicular development was induced in 23-to 24-day-old female Sprague-Dawley rats (50 -60 g, Charles River Canada, Montreal, Quebec, Canada) with DES (1 mg/day, sc, for 3 consecutive days and killed 24 h after last injection) or eCG (15 IU, ip and killed 48 h thereafter) or eCG (15 IU, ip) and followed 48 h later with hCG (15 IU, ip and killed 8 h post hCG). These treatments synchronize ovarian follicular development at predominantly the preantral/early antral, small to medium sized antral and preovulatory stages, and provide high yields of granulosa cells that are largely apoptotic, differentiated, and luteinized, respectively (19, 20) . For studies on the induction of follicular atresia by gonadotropin withdrawal (18) , rats at 23-24 days of age were injected with eCG (15 IU, sc) and 24 h later with either 100 microliters of either normal (preimmune) rabbit serum or anti-eCG antiserum (1:10 in saline; ip). Animals were killed 1 or 24 h after normal serum or antiserum injection. While DES treatment provided predominantly preantral and early antral atretic follicles (as observed in naturally occurring immature ovaries), this gonadotropin withdrawal treatment induced atresia at the early antral and small to medium sized antral stages of development (as found in ovaries of naturally occurring cycling rats). The animals were fed prolab RMH 4018 (Agway, Inc., Syracuse, NY) and water ad libitum. A 14-h light, 10-h dark cycle was maintained with light cycle initiated at 0600 h. Ovaries were excised for immunohistochemistry for IAPs and proliferation cell nuclear antigen (PCNA), and in situ terminal deoxynucleotidyl transferase-mediated dUTP-biotin end labeling (TUNEL) of apoptotic cells. In addition, granulosa cells from each group of animals were harvested by follicle puncture as previously described (20) , washed (900 ϫ g, 10 min), and resuspended in 10 mm HEPES buffer (pH 7.4) containing 1 mm EGTA and 2 mm PMSF.
In situ localization of apoptotic cells: terminal deoxynucleotidyl transferase-mediated dUTP-biotin end labeling (TUNEL)
The TUNEL was performed as described previously (21) . Briefly, paraffin-embedded whole ovarian sections (4 -5 m) were mounted on positively charged slides, deparaffinized, hydrated, and treated with proteinase-K (10 g/ml in 20 mm Tris and 2 mm CaCl 2 , pH 7.4; 37 C, 30 min) and then washed thoroughly for 15 min in Tris buffer (100 mm Tris and 150 mm NaCl, pH 7.5), followed by immersion in methanol containing 0.3% H 2 O 2 (RT, 20 min) to inhibit endogenous peroxidase activity. After rinsing in distilled water for 15 min, the sections were soaked in the TdT buffer (25 mm Tris-HCl, 200 mm sodium cacodylate, 5 mm cobalt chloride, 250 g/ml BSA, pH 6.6, 15 min) and then incubated in 50 l of TdT buffer containing 10 U TdT and 1 nmol biotinylated 16-dUTP in a humidified chamber (37 C, 60 min). The reaction was stopped by soaking sections in 2 ϫ SSC (300 mm NaCl, 30 mm sodium citrate), followed by washing in PBS (RT, 15 min). The biotinylated dUTP molecules incorporated into nuclear DNA were visualized by incubation with horseradish peroxidase-conjugated streptavidin (1:100; RT, 30 min). After further washing in PBS (15 min), the sections were immersed for 10 min in 0.05 m Tris-HCl buffer, pH 7.6, containing 0.3 mg/ml diaminobenzidine tetrahydrochloride (DAB), 0.65 mg/ml sodium azide, 10 mm imidazole, and 0.003% H 2 O 2 (peroxidase coloring reaction). The nuclei were counterstained with 5% methyl green buffered with 0.1 m veronal acetate, pH 4.0. In the negative control slides, TdT enzyme or biotinylated 16-dUTP were omitted in labeling reactions.
Immunohistochemistry
Paraffin embedded whole ovarian sections were incubated for 15 min in 0.3% H 2 O 2 for 20 min and rinsed thoroughly with PBS (3 ϫ 15 min). The sections were blocked with 1.5% normal goat serum in PBS (room temperature, 1 h) to suppress nonspecific binding of IgG, and then incubated (RT, 45 min) with rabbit polyclonal antihuman Xiap, Hiap-2 or PCNA antibodies in 1% blocking serum in PBS. After washing with PBS (3 ϫ 15 min), the sections were incubated with biotin-conjugated goat antirabbit IgG (1:200 in PBS; room temperature, 1 h), followed by avidin-biotin-peroxidase complex (room temperature, 1 h) from a Vector ABC Elite Kit. They were again washed with PBS (3 ϫ 15 min) and incubated with DAB solution (2-5 min). The nuclei were counterstained with hematoxylin. As a negative control, rabbit IgG (1 g/ml) was applied to primary antibody reaction in this experiment.
Solubilized cell extracts and immunoblot analysis
Total cell protein extracts were prepared as follow: granulosa cells were sonicated (8 s/cycle, 3 cycles) on ice in 10 mm HEPES buffer (pH 7.4) containing 1 mm EGTA and 2 mm PMSF. The sonicates were stored at Ϫ20 C until electrophoretic analyses were performed. Protein concentration was determined by the Bio-Rad protein assay.
Equal amount of proteins (60 -80 g, depending on individual experiments) present in cell extracts were resolved by one-dimensional SDS-PAGE (SDS-PAGE), and electrophoretically transferred to nitrocellulose membrane. Membranes were blocked with 5% nonfat milk and subsequently incubated with polyclonal human Xiap and Hiap-2 antibody diluted in TBS (10 mm Tris-buffered saline, pH 7.5) containing 5% milk. An ECL kit was used to visualize immunopositive protein.
DNA fragmentation analysis
DNA was extracted and labeled as previously described (22) . To 3Ј-end label DNA, 1 g of DNA was incubated with 25 U terminal deoxynucleotidyl transferase (TdT) and 5 Ci [␣ 32 P]-ddATP (3000 Ci/mmol) in 50 l of 200 mm sodium cacodylate, 5 mm cobalt chloride, 250 g/ml BSA, 25 mm Tris-HCl (pH 6.6, 37 C, 60 min) and the reaction was terminated by the addition of 5 l of 250 mm EDTA (pH 8.0). Unincorporated radionucleotide in the reactions were removed by the addition of 0.2 ϫ volume 10 m ammonium acetate and 3 ϫ volume ice-cold 100% ethanol, followed by incubation with 50 g yeast tRNA (Ϫ70 C, 60 min). The nucleic acid was collected by centrifugation (14,000 ϫ g; 4 C, 20 min), resuspended in buffer and reprecipitated with ethanol. The DNA was again pelleted by centrifugation, washed with 0.25 ml ice-cold 80% ethanol, and allowed to air dry. Samples were resuspended in TE buffer. The labeled samples were resolved by 1.8% agarose gel electrophoresis. The gel was dried (3 h) and exposed to a Bio-Rad phosphoimager screen to densitometrically quantify low molecular weight DNA (Ͻ4 Kb) and subsequently to x-ray film at Ϫ80 C.
Statistical analysis
Results were expressed as the mean Ϯ sem of three to five experiments. Statistical analysis were carried out by one-or two-way ANOVA.
Significant differences between treatment groups were determined by the Tukey test. Statistical significance was inferred at P Ͻ 0.05.
Results
Xiap and Hiap-2 were immunolocalized in both granulosa and theca cells the rat ovary during follicular development, using polyclonal antibodies against human Xiap and Hiap-2, respectively (Fig. 1) . Consistent with the concept that IAPs are intracellular proteins (11, 23) , Xiap and Hiap-2 were found in the cytoplasm and nuclei of granulosa cells from healthy follicles (Fig. 2, c and e) . In situ TUNEL and immunohistochemistry for PCNA (an auxiliary protein of DNA polymerase ␣ highly expressed at G1/S interphase) performed to study if and how Xiap and Hiap-2 expression relates to granulosa cell apoptosis and proliferation during follicular development and atresia indicates that Hiap-2 and Xiap were expressed in both granulosa and theca cells in healthy follicles (TUNEL negative; Fig. 1 , a-c), whereas they were proliferatively most active (PCNA positive: Fig. 1, e-g ). As summarized in Table 1 , Xiap and Hiap-2 were less abundant in granulosa cells from preantral ["H" (Fig. 1a) ] and early antral ["A" and "H" (Fig. 1, a and b) ] follicles where follicular atresia is frequently observed (Fig. 1, i , j, k, l, m, n, o, and p). Consistent with our present findings (Fig. 1, a-d) and those of others (6, 18, 24, 25 ) that granulosa but not theca cells undergo apoptosis, Xiap and Hiap-2 expression were greater in theca than in granulosa cells from preantral, early antral, and antral follicles (Fig. 1, i, j, k, l, m, n, o, and p) . Oocytes (Fig. 1, k and o) and ovarian surface epithelial cells (Fig. 1, l and p) also stained positively for Xiap and Hiap-2.
Atretic follicles were evident by the presence of TUNELpositive granulosa cells, uneven granulosa cell layers, and loosely attached granulosa cells that could occasionally be detected within the antral cavity (Fig. 1) . Compared with those from healthy follicles, granulosa cell PCNA staining intensity in these follicles at the preantral and early antral stages was low (Fig. 1, e and f) . However, granulosa cell proliferation was most active in healthy, small-to-medium sized antral follicles, as indicated by intense PCNA staining (Fig. 1g) . PCNA protein expression decreased dramatically in atretic follicle at this stage of development, confirming the well established notion that follicular atresia is accompanied by decreased granulosa cell proliferation (Fig. 1, g and h) . Although parts (right side) of the atretic antral follicle (Fig. 1g ) appeared somewhat stained for PCNA, close examination at higher magnification demonstrated that, in contrast to that in healthy follicles where PCNA was nucleus-specific, this GC  TC  GC  TC  GC  TC  GC  TC  GC  TC  GC  TC 
Signal intensity: Ϫ, weak; ϩ, moderate; ϩϩ, intense; ϩϩϩ, very intense. GC, Granulosa cells; TC, theca cells. might be antifactual as the heavy immunostraining of this atretic follicle was localized outside the nuclei (Fig. 2, a and  b) . Similar developmental patterns were observed in granulosa cell IAP expression, where significant decrease in Xiap (Fig. 1, m , n, o, and p) and Hiap-2 ( Fig. 1, i , j, k, and l) abundance was only evident in atretic follicles at the mid to late antral stages, suggesting a decrease in IAP expression may be associated with atresia in this follicle stage. In addition, there was a change in the intracellular distribution of IAPs in granulosa cells with the induction of atresia. Whereas granulosa cells from healthy antral follicles exhibited more intense Hiap-2 immunoreactivity in the nuclei than the cytoplasm, this IAP was predominantly localized in the extranuclear portion of the dying cells (detached from follicular wall) in atretic follicles (Fig. 2, c and d) . Although the intracellular localization of Xiap in the healthy follicles was similar to that of Hiap-2, a relatively higher proportion of Xiap immunoreactivity in granulosa cells of atretic follicles appeared to be present in the cytoplasm than in the nuclei (Fig.  2 , e and f). Interestingly, compared with healthy follicles, a decrease in theca cell IAP expression observed in atretic follicles ( Fig. 1 , k, l, o, and p) was accompanied by decreased PCNA immunoreactivity irrespective of follicular maturation ( Fig. 1 , e, f, g, and h; Table 1 ).
Further experiments were performed to confirm the results from immunohistochemistry and determine quantitatively whether granulosa cell IAP expression may be inversely related to apoptosis. Granulosa cells were isolated from follicles in DES-treated (preantral and early antral stages), eCG-treated (mid to late antral stages), and hCGtreated (preovulatory stage) treated rats. IAP expression and DNA fragmentation were analyzed by Western blot and 3Ј-end DNA labeling/agarose gel electrophoresis, respectively. As shown in Fig. 3, A and B, granulosa cell Hiap-2 (68 kDa) expression was minimal in the preantral and early antral stages of follicular development and increased with follicular maturation (P Ͻ 0.05). A similar pattern of developmental expression was also observed for Xiap (55 kDa), although the difference between the stages failed to meet statistical significance (P Ͼ 0.05; Fig. 3D ). IAP expression was inversely correlated with granulsoa cell DNA fragmentation (Fig. 3, E and F) . Apoptosis was most evident in the DES group when Hiap-2 abundance was lowest (Fig. 3, B and F) .
Gonadotropin is an important survival factor for the developing follicles to escape atresia and reach the preovulatory follicle stage (1, 4, 5, 16, 17) . Gonadotropin withdrawal induces granulosa cell apoptosis and follicular atresia (5) . In the present study, we have employed a well characterized gonadotropin withdrawal immature rat model to further study the role of IAPs in follicular atresia. Rats were injected with eCG and 24 h later with either anti-eCG antibody or normal rabbit serum (control) and ovaries were removed 1 and 24 h (i.e. 25 and 48 h after eCG injection) thereafter for granulosa cell isolation. As shown in Fig. 4 , Hiap-2 and Xiap expression was induced by eCG in vivo in a time-dependent manner (Fig. 4, A-D) . Withdrawal of gonadotropin support in the eCG-primed animals with an anti-eCG antibody markedly suppressed Hiap-2 (Fig. 4, A and B) and Xiap (Fig. 4 , C and D) expression at 24 h, compared with respective controls. These responses were accompanied by a marked increase in granulosa cell apoptosis as evident by the appearance of extensive (8-fold increase) DNA fragmentation in the antibody group compared with its respective control (Fig. 4 , E and F).
Discussion
Although the mammalian ovary is endowed with an enormous number of oocytes at birth, follicular atresia accounts for the loss of a major portion of oocyte pool and, depending on species, only about 0.1% of the oocytes eventually ovulate (26, 27) . Although follicular atresia occurs at all stages of follicular development, a large proportion of the degenerating follicles in the prepubertal ovary are found in the preantral and early antral stages and most of the atresia in the adult ovaries occurs at the transitional stages between preantral follicles and onset of antrum formation, a period often refered as the "penultimate" stage of follicular development (7) . Although responsive to gonadotropins, preantral follicular atresia appears to be initiated from the oocytes, spreads to the granulosa cells, and is not protected by the hormones. In more mature follicles, however, the granulosa cells are first to degenerate, whereas the oocytes appear to resist the onset of death before eventually regressing, and gonadotropins are important survival factors (8, 28) . While considerable advances have been made in the current understanding of the molecular and cellular mechanisms of follicular cell apoptosis, efforts in defining the physiologic basis of follicular atresia have been hampered by the lack of relevant and precise in vivo rat model for the study of this degenerative phenomenon at different stages of development, which resemble those occurring in immature and naturally cycling ovaries (18) . In the present study, we have used immature rats pretreated with eCG and eCG ϩ hCG as a model to induce ovarian follicular development and have demonstrated that the gonadotropins suppressed granulosa cell apoptosis and atresia at the antral and preovulatory stages of follicular development. In addition, treatment of immature rats with DES and eCG-pretreated animals with anti-eCG antibody (gonadotropin withdrawal) respectively induced granulosa cell apoptosis and atresia in preantral and (early) antral follicles characteristic of naturally occurring ovaries. These findings form the basis for the current investigations on the expression of IAP during follicular atresia at defined stages of development.
The recent identification of the IAP family of intracellular proteins have opened a new field of research into the molecular mechanism of apoptosis. This communication represents the first report on the cellular localization and regulation of IAP expression in the ovary. The finding that granulosa cell Xiap and Hiap-2 expression were low in preantral and early antral follicles and increased with follicular maturation is consistent with the notion that fate of these follicles (ovulation vs. atresia) is determined during these stages of the development. It is possible that IAP expression at these stages is maintained at a minimum level so as to readily afford granulosa cell apoptosis and thus follicular atresia upon receipt of an appropriate cell death stimulus. In the present study, treatment immature rats with DES markedly suppressed Hiap-2 and Xiap protein content and significantly induced apoptotic DNA fragmentation in granulosa cells of preantral follicles. The influence of estrogen on granulosa cell apoptosis is complex and appears to depend on not only the nature of the estrogenic compound, but also on the duration and the mode of administration (29, 30) . It has been demonstrated that apoptosis occurs in the preantral follicles of DES-treated rat after DES withdrawal, and this cell death process could be prevented with DES replenishment (30) . However, others reported that continuous DES administration also induced widespread atresia in the rat ovaries (31) . Irrespective of the mechanism(s) involved, it is of interest to note that, compared with those from eCG and eCG ϩ hCG-treated group, the significantly more extensive apoptotic DNA degradation (Ͼ20-fold) in DES-treated group was associated with a considerable lower Hiap-2 and Xiap abundance (approximately 5% and 60%, respectively). These data further suggest that the low IAP expression in the early stages of follicular development may be an important determinant in atresia at this follicle stage.
Previous studies have demonstrated that gonadotropins suppress granulosa cell apoptosis in preovulatory follicles and in isolated cell conditions in vitro (1, 4, 5, 16, 17) . In vivo experiments have also confirmed that follicles destined for atresia can be rescued at an early phase by exogenous gonadotropins (31, 32) , suggesting that FSH (and/or LH) is an important antiapoptogenic factor in addition to its established role in follicular development. We have demonstrated here that eCG induced Xiap and Hiap-2 expression and suppressed granulosa cell apoptosis in vivo. Withdrawal of gonadotropin support attenuated the eCG-induced granulosa cell IAP expression and markedly increased apoptotic DNA fragmentation in early antral and antral follicles. Our results raise the interesting possibility that induction of IAP expression may be an important mechanism underlying the antiatretogenic action of gonadotropin in the ovary. In addition, the current demonstration that whereas Hiap-2 and Xiap are mainly localized in the nuclei of granulosa cells from healthy follicles, the induction of granulosa cell apoptosis during follicular atresia appeared to be associated with a change in the intracellular distribution of these protein, with predominant localization being in the cytoplasm. The physiologic significant of these changes is unknown.
The signaling pathway for eCG for the up-regulation of granulosa cell IAP expression is unknown. In addition to its FSH activity, eCG also contains a low LH activity component. Binding of gonadotropins to their granulosa cell membrane receptors activates the protein kinase A (PKA) pathway (33) . In addition, it has been also demonstrated that the antiatretogenic action of FSH is partially mediated through local production of IGF-I and activation of the IGF-receptor/tyrosine kinase pathway (34) . It would be of interest to determine whether the up-regulation of Hiap-2 and Xiap expression by gonadotropins is a direct action via the PKA pathway or through indirect mechanism(s), such as the IGF signaling system.
In the ovary, as in other cell systems, cell death inducers (e.g. Fas) and survival factors [e.g. Bcl-xL and IAP (present study)] are constitutively present (35) (36) (37) (38) and the fate of the granulosa cell (survival vs. apoptosis) is determined by the balance of these opposing activities. The survival of granulosa cells in follicles that escape atresia and selected to ovulate in each reproductive cycle may occur through up-regulation of the survival factors and/or removal of the cell death inducers by an appropriate stimuli. It is possible that by inducing Hiap-2 and Xiap overexpression in granulosa cells, FSH is able to tilt the balance toward cell survival, and thus follicular growth and ovulation. Alternatively, preliminary studies from our laboratory have demonstrated that whereas gonadotropin suppressed granulosa cell Fas and Fas ligand expression in antral and preovulatory follicles in immature rats, gonadotropin withdrawal by treatment of the eCG-primed animals with anti-eCG antiserum (as in the present studies) resulted in the overexpression of these cell death factors and induced follicular atresia (36) . The relative importance of these cellular changes and the interactions of their pathways in the induction of granulosa cell apoptosis remains to be determined.
Apoptosis in atretic follicles in most mammals studied to date are confined to granulosa cells (3, 18, 24, 26) . Consistent with these findings is our observation that, irrespective of the stage of follicular maturation, theca cells in all atretic follicles were TUNEL-negative. Interestingly, Xiap and Hiap-2 were highly expressed in theca cells, and their immunoreactivities in preantral and early antral follicles were much higher than those in granulosa cells. This phenomenon may be one of the mechanisms in place to prevent theca cells from undergoing apoptosis. Alternatively, IAPs may be involved in other as yet undetermined physiological process such as theca cell differentiation. The reason(s) for the decrease of IAP expression in theca cells of atretic follicles is not known.
The mechanism (s) by which IAPs interact with established cell death pathways to regulate apoptosis is poorly understood. Recent studies reported that Hiap-2 is able to interact with signaling component of both tumor necrosis factor (TNF) receptor I and II (TNFR1 and TNFR2) pathways (15, 39) . While TNFR1 signals mainly for cytotoxicity (40) , TNFR2 has been implicated in cell proliferation or survival (41) . Using biochemical purification and subsequent molecular cloning method, Hiap-2 has been shown to be a component of the of the TNFR2 signaling complex, in which the BIR motif-containing domain interacts with TRAF2 (15). TRAF1 and TRAF2 have been shown to interact with a region within the cytoplasmic domain of TNFR2 required for signal transduction (42) . Another report has indicated that Hiap-2 is one of the component of the "survival complex" consisting of Hiap-2, TRAF2, and the TNFR1-associated death domain protein (TRADD), and that this complex is formed before TNFR1 stimulation (40) . Precisely how Hiap-2 modulate the multiple and overlapping signal transduction pathways of the two TNF receptor subtype is unknown. The possibility that Hiap-2 may be inhibitory in one (TNFR1) and stimulatory in another (TNFR2) is intriguing and cannot be excluded. In the latter context, recent study by Lee et al.(43) has suggested that human IAPs, via interaction with TRAF2, facilitate TNF␣-induced cell proliferation. In our study, Hiap-2 expression was higher in follicles where granulosa and theca cells were proliferatively active (PCNA positive), thus also raising the possibility that Hiap-2 could play a role in the regulation of follicular cell proliferation in the ovary. Whether this indeed is the case awaits further investigation.
Moreover, recent study by Daveraux et al. (44) has demonstrated that Xiap inhibits caspase-3, a "cell death" protease downstream on the TNFR1 pathway, and suppresses apoptosis. Interestingly, granulosa cells from ovarian atretic follicles induced by eCG withdrawal exhibited considerably higher caspase-3 immunoactivity compared with those from healthy ones (Boone, D. L. and B. K. Tsang, unpublished data). It is thus possible that, in addition to its up-regulation during the induction of granulosa cell apoptosis by gonadotropin withdrawal, caspase-3 may be an additional point of regulation by IAP. Whether these regulatory mechanisms exist for the antiapoptotic action of gonadotropin in the ovary remains to be determined.
In summary, Xiap and Hiap-2 are expressed in rat granulosa and theca cells during follicular development, and the abundance of IAPs in granulosa cells is regulated during follicular development and atresia in an antiapoptotic fashion. IAPs appear to be an intracellular protein family important in the "life" and "death" decision of granulosa cells during follicular selection and may play a critical role as a cell survival factor in the control of stage-specific follicular atresia during development.
